Article
VCAN – A novel prognostic marker for gastric cancer
2019-09-12
Abstract excerpt
<h4>Background: </h4> Versican (VCAN) is a large aggregating extracellular matrix proteoglycan implicated in the pathogenesis of most human cancers but its role in gastric cancer is not yet elucidated. We designed the present study to investigate the expression, prognostic value, relationship between genetic alterations and patient’s outcome, disease associations, as well as genetic and protein interactions of VCA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2c863a90-67c4-51e1-a548-5dd3dddd4e4e
- DOI
- 10.21203/rs.2.14320/v1